Racの活性化と無活性化は,腫瘍細胞の動きの可塑性を制御する
Victoria Sanz-Moreno1, Gilles Gadea, Jessica Ahn
1Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, UK.
Cell
|November 6, 2008
まとめ
腫瘍細胞は,RhoとRacの信号伝達経路を調節することによって,メゼンキマとアミーボイドの動きを切り替えます. この研究は,これらの重要な細胞移動モードを制御する重要な分子プレーヤーを特定します.
科学分野:
- 細胞生物学 細胞生物学
- がん研究 がん研究
- 分子生物学は分子生物学である.
背景:
- 腫瘍細胞は,メゼンキマとアメーボイドの異なった移動様式を示しています.
- メセンキマの動きには,伸びた細胞,タンパク質分解,Racシグナル伝達が含まれています.
- アモエボイドの動きには,丸い細胞,ロキナーゼシグナル伝達,アクトミオシン収縮性の高い特徴があります.
研究 の 目的:
- メゼンキーマ細胞とアミーボイド腫瘍細胞の動きの間の相互変換を制御する分子機構を解明する.
- これらの異なる細胞移動モードを調節する重要なシグナル伝達経路とタンパク質を特定する.
主な方法:
- GTPases RacとRho-kinaseのシグナル伝達が細胞形態と運動を調節する役割について調査した.
- RacとRhoの活性について研究するために,NEDD9,DOCK3,WAVE2,ARHGAP22を含む分子複合体を活用しました.
- 腫瘍細胞の移住を制御する際にRhoとRacの信号伝達経路の相互作用を分析した.
主要な成果:
- メセンキマの動きは,Racの活性化によって,NEDD9-DOCK3複合体経由で誘発され,その複合体は,WAVE2.2経由で信号を発信する.
- Racの活性化は,アクトミオシン収縮性を抑制し,アミーボイドの動きを抑制します.
- ロキナーゼシグナル伝達は,RAC GAPであるARHGAP22を活性化させ,RACを無活性化することでメゼンキマの動きを抑制する.
結論:
- 腫瘍細胞の移動モードは,RhoとRacのシグナル伝達の間のダイナミックな相互作用によって決定されます.
- これらのスイッチングメカニズムの理解は,メラノーマの転移と潜在的な治療目標についての洞察を提供します.
関連する概念動画
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cell Polarization by Rho Proteins
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...


